HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print May 27, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.0804456v1 78/2/372    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scottà, C. Articles by Frasca, L. Search for Related Content PubMed PubMed Citation Articles by Scottà, C. Articles by Frasca, L.

(Journal of Leukocyte Biology. 2005;78:372-382.)
© 2005 by Society for Leukocyte Biology

Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4⁺ T cell repertoire by favoring CD95-mediated apoptosis

Cristiano Scottà^*, Loretta Tuosto^*, Anna Maria Masci^,, Luigi Racioppi, Enza Piccolella^* and Loredana Frasca^*,1

^* Department of Cellular and Developmental Biology, La Sapienza University, Rome, Italy;
Department of Cellular and Molecular Biology and Pathology, Federico II University, Naples, Italy; and
IRCCS San Raffaele, Rome, Italy

¹ Correspondence: Department of Cellular and Developmental Biology, La Sapienza University, Rome, 00185, Italy. E-mail: lfrasca{at}iss.it

We have described previously that hypervariable region 1 (HVR1) variants of hepatitis C virus (HCV) frequently act as T cell receptor (TCR) antagonists for HVR1-specific helper T cells. These naturally occurring HVR1-antagonistic sequences interfered with the effects of HVR1-agonistic sequences such as TCR down-regulation and early activatory signals. By taking advantage of these findings, in this paper, we have analyzed the fate of these HVR1-specific antagonized CD4⁺ T cells. We present the evidence that TCR antagonism renders agonist-activated T cells susceptible to bystander CD95-mediated killing by suppressing the expression of cellular Fas-associated death domain-like interleukin-1ß-converting enzyme-like inhibitor proteins. To verify whether the TCR repertoire of a HVR1-specific T cell population could be modified consequently, we used a HVR1-agonistic sequence to induce in vitro CD4⁺ T cells and another HVR1 sequence with antagonistic property to mediate suppressive phenomena. HVR1-specific T cells were cultured with the agonist alone or with the agonist plus the antagonist. HVR1 specificity and T cell repertoires were followed over time by analyzing TCR ß-variable gene segment by "spectratyping". The results showed that the specificity for the agonist was rapidly spoiled after culture in the presence of the antagonist, and the TCR repertoire was strongly modified as a result of CD95-mediated apoptosis of agonist-specific clonal expansions. These data support the hypothesis that in HCV infection, the generation of TCR antagonists may reshape the T cell repertoire, representing an efficacious immune evasion strategy of a highly mutant pathogen.

Key Words: HCV infection • T cell deletion • altered peptide ligands • spectratyping

This article has been cited by other articles:

				L. Frasca, G. Fedele, S. Deaglio, C. Capuano, R. Palazzo, T. Vaisitti, F. Malavasi, and C. M. Ausiello CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells Blood, March 15, 2006; 107(6): 2392 - 2399. [Abstract] [Full Text] [PDF]